The system is the latest addition to the hospital’s newly installed £7.8m theatres and is designed to provide surgeons with greater flexibility and precision across a wide range of minimally-invasive surgical procedures.
Firefly fluorescence imaging has been built into the da Vinci Xi robot to give surgeons real-time visualisation and assessment of vessels, bile ducts, and tissue perfusion. This enables better access during complex procedures and leads to faster recovery times, less post-operative pain, and lower rates of surgical complications.
HCA UK Joint Ventures CEO Claire Smith said the system enhanced the hospital’s capability and opened up new routes to minimally invasive and complex surgery.
‘We are incredibly proud to be the first in the region to offer this technology in the independent sector ensuring that when it comes to cancer care, we are uniquely positioned to be able to support patients throughout their clinical pathway,’ she added.